Navigation Links
Webcast Alert: Isis Pharmaceuticals Announces a Business Update Conference Call
Date:7/1/2008

CARLSBAD, Calif., July 1 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announces the following webcast:

What: Isis Pharmaceuticals' business update

When: Tuesday, July 1, 2008, at 10:00 a.m. ET / 7:00 a.m. PT

Via internet: Simply log onto our web site http://www.isispharm.com and click on the webcast icon on our home page.

Via telephone: In the United States, call 1-877-548-7901 five to ten minutes prior to the call. You will be asked to provide your name and indicate that you wish to participate in Isis Pharmaceuticals' conference call hosted by Dr. Stanley Crooke.

Contacts: Kristina Lemonidis

Associate Director, Investor Relations

(760) 603-2490

Amy Blackley, Ph.D.

Manager, Corporate Communications

(760) 603-2772

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The Company has successfully commercialized the world's first antisense drug and has 18 drugs in development. Isis' drug development programs are focused on treating cardiovascular and metabolic diseases. Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases. Ibis Biosciences, Inc., Isis' majority-owned subsidiary, is developing and commercializing the Ibis T5000(TM) Biosensor System, a revolutionary system to identify infectious organisms. Isis is a joint owner of Regulus Therapeutics LLC, a joint venture focused on the discovery, development and commercializat
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Boston Scientific To Webcast Conference Call Discussing Second Quarter Financial Results
2. deCODE genetics to Webcast Presentations at Annual R&D Event
3. deCODE genetics to Webcast Presentation at Piper Jaffray Europe Conference
4. Exelixis Announces June 25 Webcast of Presentation at the Piper Jaffray Europe Conference
5. Parexel Invites Public to Listen to Live Webcast of Its Investor Day June 25, 2008
6. Schering-Plough Schedules Conference Call and Webcast for 2008 Second Quarter Earnings
7. Gen-Probe to Webcast Presentation at the William Blair & Company 28th Annual Growth Stock Conference
8. Exelixis Announces June 19 Webcast of Presentation at the William Blair 28th Annual Growth Stock Conference
9. Gen-Probe to Webcast Presentation at Seventh Annual Needham Biotechnology and Medical Technology Conference
10. Telik Announces Presentation and Webcast at Needham Biotechnology Conference
11. Exelixis Announces June 5 Webcast of Conference Call Regarding Its $150 Million Funding Commitment from Deerfield Management

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...ire/ -- Myriant Technologies LLC ("Myriant"), a pr...f renewable bio-chemicals, Uhde Corporation of Am...mbH, one of the world,s leading engineering contra...the engineering, procurement & construction (E...ed on renewable feedstocks. The execution of this...
(Date:11/6/2009)...rstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDA...unced updated results from a Phase II study of int...astatic to the lung in a poster presentation at th...eeting held in Miami Beach, Florida, from November...Phase II Study of Intravenous REOLYSIN (Wild-type ...
(Date:11/5/2009)...ewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC ...ird quarter ended September 30, 2009. GenVec repor...or the three months ended September 30, 2009 compa...) in the comparable quarter of 2008. For the nine ... was $14.1 million ($0.15 per share), compared to ...
(Date:11/5/2009)... ThermoGenesis Corp. (Na...oducts for processing and storing adult stem cells...fiscal 2010. ,, For the quarter ended September...illion, a 15 percent increase over revenues of $4....pany said the key contributors to the growth in re...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8
...rmaceuticals Inc. (Nasdaq: VNDA ), a biopharmace...ercialization of clinical-stage product candidates...nced financial and operational results for the fir...rted a net loss of $6.5 million for the first quar...th quarter of 2008. Total expenses for the first ...
..., - Increases Accessibility to Market-Leading ...ing publisher of scientific, technical, and,medica...ay that ten new eBook,Specialty Collections have l...,its online clinical reference tool. This launch p...ialty content in Dermatology, Dermatologic Surgery...
...e as usual pending Nasdaq listing review , , REYK... DCGN ) announced that it has this evening recei...eview Council stating that the Council has called ...q Listing Qualifications Panel regarding the delis... Stock Market. Pending the completion of this revi...
Other Biology Technology:Vanda Pharmaceuticals Reports First Quarter 2009 Results 2Vanda Pharmaceuticals Reports First Quarter 2009 Results 3Vanda Pharmaceuticals Reports First Quarter 2009 Results 4Vanda Pharmaceuticals Reports First Quarter 2009 Results 5Vanda Pharmaceuticals Reports First Quarter 2009 Results 6Vanda Pharmaceuticals Reports First Quarter 2009 Results 7Vanda Pharmaceuticals Reports First Quarter 2009 Results 8Vanda Pharmaceuticals Reports First Quarter 2009 Results 9Vanda Pharmaceuticals Reports First Quarter 2009 Results 10Elsevier Launches Ten New eBook Specialty Collections on MD Consult 2Elsevier Launches Ten New eBook Specialty Collections on MD Consult 3Nasdaq Stays Suspension of Trading in deCODE Stock 2Nasdaq Stays Suspension of Trading in deCODE Stock 3
(Date:11/9/2009)... marine plants called phytoplankton are flourishin...t and rapid melting of ice shelves and glaciers ar...nisation is having a beneficial impact on climate ... to the sea-bed where it can store carbon for thou...ek in the journal Global Change Biology , scienti...
(Date:11/9/2009)...ren with cancer, the hopeful news is that pediatri...s. Among the bad newstreatments that enable surviv...ith cancer who have reached puberty currently have...e undergoing cancer treatment, they may have their...r boys, however, do not produce sperm, although th...
(Date:11/9/2009)...N.Y. Oncologists have had their hands tied becaus...ns that disable a protein called p53. As a critica...ncer-fighting operations within cells. When cells ...t be treated. , These tumors might be tough, bu...m Cold Spring Harbor Laboratory (CSHL). The chink ...
Breaking Biology News(10 mins):Antarctica glacier retreat creates new carbon dioxide store 2For young boys with cancer, testicular tissue banking may be option to preserve fertility 2For young boys with cancer, testicular tissue banking may be option to preserve fertility 3CSHL study shows that some malignant tumors can be shut down after all 2CSHL study shows that some malignant tumors can be shut down after all 3FDA Clears a Test for Ovarian Cancer 4972 1FDA Clears a Test for Ovarian Cancer 4972 2Professor Uses H1N1 as a Teaching Tool 56956 1Professor Uses H1N1 as a Teaching Tool 56956 2Professor Uses H1N1 as a Teaching Tool 56956 3Muslim Coalition to Host D C Hearing on Health Care Reform 56951 1Muslim Coalition to Host D C Hearing on Health Care Reform 56951 2
...ease is available in Spanish . , The SUPERCABL...aterial Science of Barcelona (ICMAB-CSIC), at the ...nd the company Nexans, received the NOVARE Prize i...y ENDESA. The 500,000 prize will be invested in de...south of Europe and the most advanced in the world...
... MA, AND WASHINGTON, DCThe University of Massachus...f Washington announced today that they have entere...(LSE: OXB), a gene therapy company, that grants t...atent rights. , The technology was invented by ..., and Craig C. Mello, PhD, and their colleagues. T...
...tor-in-Chief of Experimental Biology and Medicine ...n for expansion of the journal and enhancement of ...ogy and Medicine (SEBM) into Asia. The plan, whic...ves bringing outstanding Asian researchers onto th...om amongst the leaders in Asian Biomedical Science...
Other Biology News:CSIC and UAB will build the most advanced superconductor cable for electricity network 2CSIC and UAB will build the most advanced superconductor cable for electricity network 3UMMS and CIW grant key RNAi rights to Oxford Biomedica 2Experimental Biology and Medicine announces expansion into Asia, opens new office 2Experimental Biology and Medicine announces expansion into Asia, opens new office 3
Acridine orange, hemizinc salt from Research Organics, Inc.
Acridine orange 10-nonyl bromide from AnaSpec
Anti-rat Ig HRP detection kit from BD Biosciences Pharmingen
Wash Solution from CHEMICON
Biology Products: